Suppression of MAPK signaling in BRAF ‐activated PTEN‐deficient melanoma by blocking β‐catenin signaling in cancer‐associated fibroblasts
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 297-307, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 17, 2017 Category: Cytology Source Type: research
---
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 238-240, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 17, 2017 Category: Cytology Source Type: research
---
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 277-286, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 17, 2017 Category: Cytology Source Type: research
---
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 297-307, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 17, 2017 Category: Cytology Source Type: research
Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi
In conclusion, the MC1R gene appears to influence the nevus phenotype. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 17, 2017 Category: Cytology Authors: Mar ía Gabriela Vallone, Gemma Tell‐Marti, Miriam Potrony, Aida Rebollo‐Morell, Celia Badenas, Joan Anton Puig‐Butille, Pol Gimenez‐Xavier, Cristina Carrera, Josep Malvehy, Susana Puig Tags: ORIGINAL ARTICLE Source Type: research
Leptomeningeal melanoma —A case series in the era of modern systemic therapy
(Source: Pigment Cell Research)
Source: Pigment Cell Research - October 17, 2017 Category: Cytology Authors: Malmaruha Arasaratnam, Angela Hong, Brindha Shivalingam, Helen Wheeler, Alexander D. Guminksi, Georgina V. Long, Alexander M. Menzies Tags: LETTER TO THE EDITOR Source Type: research
Suppression of MAPK signaling in BRAF ‐activated PTEN‐deficient melanoma by blocking β‐catenin signaling in cancer‐associated fibroblasts
This article is protected by copyright. All rights reserved. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 17, 2017 Category: Cytology Authors: Linli Zhou, Kun Yang, Spencer Dunaway, Zalfa Abdel ‐Malek, Thomas Andl, Ana Luisa Kadekaro, Yuhang Zhang Tags: Original Article Source Type: research
Photodynamic therapy inhibits melanogenesis through paracrine effects by keratinocytes and fibroblasts
This article is protected by copyright. All rights reserved. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 17, 2017 Category: Cytology Authors: Sue Kyung Kim, Seung ‐Jae Oh, Se‐Yeon Park, Woo‐Jung Kim, You‐Sun Kim, You Chan Kim Tags: Original Article Source Type: research
Targeting cholesterol transport in circulating melanoma cells to inhibit metastasis
This study investigates whether targeting cholesterol transport in melanoma CTCs can retard metastasis development. Nanolipolee‐007, the liposomal form of leelamine, reduced melanoma metastasis in both a novel in vitro flow system mimicking the circulating system and in experimental as well as spontaneous animal metastasis models, irrespective of the BRAF mutational status of the CTCs. Leelamine led to cholesterol trapping in lysosomes, which subsequently shut down receptor‐mediated endocytosis, endosome trafficking, and inhibited the major oncogenic signaling cascades important for survival such as the AKT pathway. As...
Source: Pigment Cell Research - October 15, 2017 Category: Cytology Authors: Yu ‐Chi Chen, Raghavendra Gowda, Raymond K. Newswanger, Patrick Leibich, Barry Fell, Gerson Rosenberg, Gavin P. Robertson Tags: ORIGINAL ARTICLE Source Type: research
Quality ‐of‐life outcomes in patients with advanced melanoma: A review of the literature
Summary
For patients with metastatic melanoma, the emergence of immune checkpoint inhibitors and targeted BRAF and MEK inhibitors has markedly enhanced clinical outcomes compared with chemotherapy. However, these novel agents are also associated with unique sets of adverse events, and increased overall survival can lead to prolonged exposure to some novel agents. Therefore, clinical evaluation of these therapies has now included the analysis of health‐related quality of life (HRQoL) in addition to more traditional efficacy and safety outcomes as a measure of patient perception of benefit. The current review focuses on HR...
Source: Pigment Cell Research - October 13, 2017 Category: Cytology Authors: Karen A. Malkhasyan, Yousef Zakharia, Mohammed Milhem Tags: REVIEW Source Type: research
The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 287-296, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 9, 2017 Category: Cytology Source Type: research
---
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 287-296, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 9, 2017 Category: Cytology Source Type: research
Escaping BRAF inhibition: A “linc” with non‐coding RNAs?
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 236-237, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 6, 2017 Category: Cytology Source Type: research
---
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 236-237, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 6, 2017 Category: Cytology Source Type: research
Lessons of a day hospital: Comprehensive assessment of patients with albinism in a European setting
Pigment Cell&Melanoma Research,Volume 31, Issue 2, Page 318-329, March 2018. (Source: Pigment Cell Research)
Source: Pigment Cell Research - October 4, 2017 Category: Cytology Source Type: research
